Literature DB >> 33516259

Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.

Po-Hsuan Lai1, Ting-Hsuan Wang1, Nai-You Zhang1, Kuo-Chen Wu1, Chung-Chen Jane Yao2, Chun-Jung Lin3.   

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is characterized by synovial inflammation, cartilage damage, and systemic inflammation. RA is also associated with the occurrence of neuroinflammation and neurodegenerative diseases. In this study, the impacts of RA on the function of the blood-brain barrier (BBB) and the disposition of amyloid beta (Aβ), including BBB transport and peripheral clearance of Aβ, were investigated in rats with collagen-induced arthritis (CIA), an animal model with similarity to clinical and pathological features of human RA.
METHODS: CIA was induced in female Lewis rats. In addition to neuroinflammation, the integrity and function of the BBB were examined. The expression of Aβ-transporting proteins at brain blood vessels was measured. Blood-to-brain influx and plasma clearance of Aβ were determined.
RESULTS: Both microgliosis and astrogliosis were significantly increased in the brain of CIA rats, compared with controls. In terms of BBB function, the BBB permeability of sodium fluorescein, a marker compound for BBB integrity, was significantly increased in CIA rats. Moreover, increased expression of matrix metalloproteinase-3 (MMP-3) and MMP-9 and decreased expression of tight junction proteins, zonula occludens-1 (ZO-1) and occludin, were observed in brain microvessels of CIA rats. In related to BBB transport of Aβ, protein expression of the receptor of advanced glycation end product (RAGE) and P-glycoprotein (P-gp) was significantly increased in brain microvessels of CIA rats. Notably, much higher expression of RAGE was identified at the arterioles of the hippocampus of CIA rats. Following an intravenous injection of human Aβ, significant higher brain influx of Aβ was observed in the hippocampus of CIA rats.
CONCLUSIONS: Neuroinflammation and the changes of BBB function were observed in CIA rats. The increased RAGE expression at cerebral blood vessels and enhanced blood-to-brain influx of Aβ indicate the imbalanced BBB clearance of Aβ in RA.

Entities:  

Keywords:  Amyloid beta; Blood-brain barrier; Collagen-induced arthritis; P-glycoprotein; Receptor of advanced glycation end product

Year:  2021        PMID: 33516259      PMCID: PMC7847579          DOI: 10.1186/s12974-021-02086-2

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  47 in total

1.  Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

Authors:  Jorge Ghiso; Marcos Shayo; Miguel Calero; Douglas Ng; Yasushi Tomidokoro; Samuel Gandy; Agueda Rostagno; Blas Frangione
Journal:  J Biol Chem       Date:  2004-08-20       Impact factor: 5.157

2.  Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo.

Authors:  J R Ghilardi; M Catton; E R Stimson; S Rogers; L C Walker; J E Maggio; P W Mantyh
Journal:  Neuroreport       Date:  1996-11-04       Impact factor: 1.837

3.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

4.  Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis.

Authors:  Richard C Chou; Michael Kane; Sanjay Ghimire; Shiva Gautam; Jiang Gui
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

5.  Blood-derived amyloid-β protein induces Alzheimer's disease pathologies.

Authors:  X-L Bu; Y Xiang; W-S Jin; J Wang; L-L Shen; Z-L Huang; K Zhang; Y-H Liu; F Zeng; J-H Liu; H-L Sun; Z-Q Zhuang; S-H Chen; X-Q Yao; B Giunta; Y-C Shan; J Tan; X-W Chen; Z-F Dong; H-D Zhou; X-F Zhou; W Song; Y-J Wang
Journal:  Mol Psychiatry       Date:  2017-10-31       Impact factor: 15.992

Review 6.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

Review 7.  Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier.

Authors:  Fabien Gosselet; Julien Saint-Pol; Pietra Candela; Laurence Fenart
Journal:  Curr Alzheimer Res       Date:  2013-12       Impact factor: 3.498

Review 8.  Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.

Authors:  Philip B Gorelick
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

9.  RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

Authors:  John E Donahue; Stephanie L Flaherty; Conrad E Johanson; John A Duncan; Gerald D Silverberg; Miles C Miller; Rosemarie Tavares; Wentian Yang; Qian Wu; Edmond Sabo; Virginia Hovanesian; Edward G Stopa
Journal:  Acta Neuropathol       Date:  2006-07-25       Impact factor: 17.088

10.  Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.

Authors:  Robert J Andrew; Celia G Fernandez; Molly Stanley; Hong Jiang; Phuong Nguyen; Richard C Rice; Virginie Buggia-Prévot; Pierre De Rossi; Kulandaivelu S Vetrivel; Raza Lamb; Arnau Argemi; Emilie S Allaert; Elle M Rathbun; Sofia V Krause; Steven L Wagner; Angèle T Parent; David M Holtzman; Gopal Thinakaran
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

View more
  3 in total

1.  Equilibrative Nucleoside Transporter 1 is a Target to Modulate Neuroinflammation and Improve Functional Recovery in Mice with Spinal Cord Injury.

Authors:  Kuan-Yu Chen; Chiao-Shin Lu; Cheng-Yoong Pang; Chin-Jui Ho; Kuo-Chen Wu; Hsiu-Wei Yang; Hsin-Lin Lai; Yijuang Chern; Chun-Jung Lin
Journal:  Mol Neurobiol       Date:  2022-10-21       Impact factor: 5.682

2.  A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders.

Authors:  Eric Delpire; Yehezkel Ben-Ari
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

3.  Effects of Mild and Moderate Monoclonal Antibody Dose on Inflammation, Bone Loss, and Activation of the Central Nervous System in a Female Collagen Antibody-induced Arthritis Mouse Model.

Authors:  Bonnie Williams; Florence Lees; Helen Tsangari; Mark R Hutchinson; Egon Perilli; Tania N Crotti
Journal:  J Histochem Cytochem       Date:  2021-07-22       Impact factor: 4.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.